The 8th Annual T-cell Lymphoma Forum is a 2½-day meeting focusing on the latest information on novel agents and treatment approaches. The Forum, cochaired by Francine M. Foss, MD, Owen A. O'Connor, MD, PhD, and Kensei Tobinai, MD, PhD, will be held at the Fairmont Hotel, San Francisco, from January 28-30, 2016.
As in years past, Drs Foss, O'Connor, and Tobinai have produced a comprehensive program intended to inform attendees on the latest research on T-cell lymphoma, including global epidemiology and pathology, immuno-oncology, targeting molecular pathways, new therapeutic approaches, and an update on cutaneous disease. Attendees will have the opportunity to interact with global T-cell lymphoma clinical and industry experts.
This year's keynote address will be made by Randy D. Gascoyne, MD. Dr. Gascoyne is the Research Director of the Centre for Lymphoid Cancer at the BC Cancer Agency, as well as a clinician-scientist at the BCCA/BCCRC and a Clinical Professor at the University of British Columbia. He participated as a speaker discussing gene expression profiling in the inaugural T-cell Lymphoma Forum in 2008.
The T-cell Lymphoma Forum provides just the platform for attendees and world leaders in TCL to gather and exchange ideas and information to improve outcomes for this patient population. Plan to join our distinguished international faculty for this informative program.
This meeting is intended for hematologists, oncologists, and other clinicians and scientists with an interest in T-cell lymphoma.
We look forward to that having you participate in what we anticipate will be a very stimulating program.